Skip to main content

Table 3 Distribution of the R497K and (CA)n genotypes according to prognostic variables

From: Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer

Prognostic variables

 

R497K

 

(CA)n

Arg/Arg

Arg/Lys

Lys/Lys

 

Short/short

Short/long

Long/long

 

Total

n = 308

n = 176

n = 21

Total

n = 108

n = 230

n = 139

 
 

n

%

%

%

P

n

%

%

%

P

Age

          

  > 35 years-old

493

61.7

34.1

4.3

0.06

466

22.7

48.5

28.8

0.48

  ≤ 35 years-old

112

33.3

66.7

0.0

 

11

18.2

36.4

45.5

 

Familial history

          

 No

400

60.0

36.0

4.0

0.99

376

21,5

49,7

28,7

0.38

 Yes

56

60.7

35.7

3.6

 

53

26,4

39,6

34.0

 

Histological type

          

in situ

35

62.9

34.3

2.9

0.91

33

15.2

48.5

36.4

0.44

 Invasive

459

61.0

34.6

4.4

 

434

23.3

48.6

28.1

 

Tumor grade

          

 Grade 1

60

56.7

40.0

3.3

0.64

58

25.9

46.6

27.6

0.74

 Grade 2 or 3

413

61.3

34.1

4.6

 

389

21.3

48.8

29.8

 

Tumor size

          

 pT ≤ 2 cm

224

59.4

36.6

4.0

0.65

214

22.9

45.3

31.8

0.24

 pT > 2 cm

233

62.7

32.6

4.7

 

218

23.4

51.8

29.8

 

Lymph node status

          

 pN0 or pN1

429

58.0

37.3

4.7

0.005

405

22.7

47.2

30.1

0.47

 pN2 or pN3

76

77.6

21.1

1.3

 

72

22.2

54.2

23.6

 

ER status

          

 Negative

76

68.4

27.6

3.9

0.38

72

26.4

51.4

22.2

0.29

 Positive

411

60.1

35.5

4.4

 

387

21.2

47.8

31.0

 

PR status

          

 Negative

133

63.2

32.3

4.5

0.87

128

28.1

50.0

21.9

0.031

 Positive

353

60.9

34.8

4.2

 

330

19.4

47.9

32.7

 

HER2 status

          

 Negative

376

59.3

35.6

5.1

0.13

356

21.9

50.0

28.1

0.30

 Positive

72

65.3

34.7

0.0

 

67

20.9

41.8

37.3

 

Biological classification

          

 Luminal A

291

58.8

36.4

4.8

0.68

275

20.0

49.8

30.2

0.35

 Luminal B

88

60.2

36.4

3.4

83

21.7

43.4

34.9

 HER2 like

26

73.1

26.9

0.0

24

37.5

41.7

20.8

 Triple negative

44

63.6

29.5

6.8

 

42

23.8

54.8

21.4

 
  1. Data are expressed as the number of patients and respective percentages in each category. (CA)n Short: n ≤ 16; (CA)n Long: n > 16. Abbreviations: ER Estrogen Receptor, PR Progesterone Receptor, HEr2 Human Epidermal groth factor Receptor 2. Statistically significant differences are presented in bold characters.